Mepha / Teva Switzerland is a prominent pharmaceutical company based in Basel, operating as part of the global Teva Group since 2011. The company employs around 150 to 200 people and is recognized as the leading player in the Swiss generics market, offering a diverse portfolio of over 230 branded and non-branded generic medicines across 18 medical indication areas.

The company develops, manufactures, and markets a wide range of pharmaceutical products, including generic drugs, original medicines, over-the-counter (OTC) products, and biologicals. Many of these products are produced in Switzerland, adhering to high Swiss-quality standards. Mepha's research and development efforts focus on enhancing branded generics through innovative formulations and drug delivery technologies, as well as researching malaria treatments for both adults and children.

Mepha / Teva Switzerland distributes its products primarily to pharmacies, self-dispensing doctors, drugstores, and hospitals within Switzerland. The company also has subsidiaries in Portugal and the Baltic States and markets its products through partnerships in various regions, including Europe, the Middle East, Africa, and the Americas, showcasing its international reach.